Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients.

Turner, R; Holman, R; Matthews, D; Bassett, P; Coster, R; Stratton, I; Cull, C; Peto, R; Frighi, V; Kennedy, I; Manley, S; Bown, E; Eeley, E; Ross, I; Matthews, D; Dornan, T; Wright, A; Neil, H; Kohner, E; Aldington, S; Keen, N; Rose, C; Fletcher, A; Battersby, C; Yudkin, J

Journal article

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients.

Abstract:: OBJECTIVE: To determine the degree to which hypertension is a risk factor for macrovascular and microvascular complications in type 2 diabetes. DESIGN: Observational prospective study. SUBJECTS: Newly diagnosed Type 2 diabetic patients recruited into the UK Prospective Diabetes Study (n = 3648; mean age 52 years), 40% of whom were hypertensive (blood pressure > or = 160 mmHg systolic and/or > or = 90 mmHg diastolic or already being treated for hypertension). MEASUREMENTS: The incidence of fatal and non-fatal major diabetes- and hypertension-related clinical events was determined over a median of 4.6 years' follow-up. The 3-year change in prevalence of subclinical indices of macrovascular and microvascular disease was assessed, including ECG abnormalities (Minnesota coding), left ventricular hypertrophy (ECG and chest x-ray), microalbuminuria (albumin/creatinine ratio) and moderately severe retinopathy (grading of retinal photographs). RESULTS: The hypertensive patients had (1) a greater incidence than normotensive patients of death from diabetes-related, mainly cardiovascular events (age-adjusted odds ratio 1.82) and (2) a greater incidence of diabetes-related death and major morbidity combined, including myocardial infarctions, angina, strokes and amputation (age-adjusted odds ratio 1.56). These associations were still present after allowance for other risk factors present at the time diabetes was diagnosed. The change in the prevalence of microvascular disease over 3 years was similar in both hypertensive and normotensive subjects. CONCLUSIONS: Hypertension is a major risk factor for cardiovascular morbidity and mortality in type 2 diabetes. Comparison with other studies suggests that patients with both hypertension and diabetes have approximately four times the cardiovascular risk of non-diabetic non-hypertensive subjects. Antihypertensive therapy may provide greater benefit in this high-risk group than in the general population.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Turner, R., Holman, R., Matthews, D., Bassett, P., Coster, R., Stratton, I., Cull, C., Peto, R., Frighi, V., Kennedy, I., Manley, S., Bown, E., Eeley, E., Ross, I., Matthews, D., Dornan, T., Wright, A., Neil, H., Kohner, E., … Yudkin, J. (1993). Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. Journal of Hypertension, 11(3), 319–325.

MLA Style

Turner, R, et al. “Hypertension in Diabetes Study (HDS): II. Increased Risk of Cardiovascular Complications in Hypertensive Type 2 Diabetic Patients.” Journal of Hypertension, vol. 11, no. 3, 1993, pp. 319–25.

Chicago Style

Turner, R, R Holman, D Matthews, et al. 1993. “Hypertension in Diabetes Study (HDS): II. Increased Risk of Cardiovascular Complications in Hypertensive Type 2 Diabetic Patients.” Journal of Hypertension 11 (3): 319–25.
Print